News

Pharmabiz7m
Theriva Biologics presents data from phase 1b/2a trial of ribaxamase in allogeneic hematopoietic cell transplant recipients
Rockville, Maryland Saturday, April 12, 2025, 18:00 Hrs [IST] ...
Pharmabiz1h
Adaptin Bio completes alternative public offering and closes $7.7 million private placement
Adaptin Bio completes alternative public offering and closes $7.7 million private placement: Charlotte, NC Saturday, April 12, 2025, 17:00 Hrs [IST] Adaptin Bio, Inc, a biotechnol ...
Pharmabiz2h
Oncodesign Services appoints Aidan Synnott as CEO to enhance drug discovery
Oncodesign Services, a contract research organization specializing in drug discovery and preclinical development, appointed Dr. Aidan Synnott as chief executive officer, to help strengthen its ...
Pharmabiz3h
Phio Pharmaceuticals announces Safety Monitoring Committee recommendation to advance INTASYL PH-762 skin cancer study
Phio Pharmaceuticals announces Safety Monitoring Committee recommendation to advance INTASYL PH-762 skin cancer study: Marlborough, Massachusetts Saturday, April 12, 2025, 15:00 H ...
Pharmabiz3h
IPU 2025 to usher in a new era of digital, inclusive, and accountable healthcare
IPU 2025 to usher in a new era of digital, inclusive, and accountable healthcare: Our Bureau, Mumbai Saturday, April 12, 2025, 14:30 Hrs [IST] The International Patients’ Union ...
Pharmabiz3h
AMTZ joins hands with FORGE to build India’s strongest medtech innovation ecosystem
In a landmark move to accelerate India's medtech innovation ecosystem, the Andhra Pradesh MedTech Zone (AMTZ) has partnered with FORGE Innovation & Ventures to launch a state-of-the-art Forge Factory, ...
Pharmabiz4h
Forma Medical expands minimally invasive surgery portfolio; includes OptimalTMT, an innovative lapidus plating system
Forma Medical expands minimally invasive surgery portfolio; includes OptimalTMT, an innovative lapidus plating system: Camp Hill, PA Saturday, April 12, 2025, 14:00 Hrs [IST] Form ...
Pharmabiz5h
Orexo announces positive data for powder-based intranasal vaccine formulated with the AmorphOX technology
Orexo announces positive data for powder-based intranasal vaccine formulated with the AmorphOX technology: Uppsala, Sweden Saturday, April 12, 2025, 13:00 Hrs [IST] Orexo AB (publ ...
Pharmabiz7h
Aspire Biopharma begins phase 1 clinical trial of oral transmucosal fast-acting high-dose aspirin formulation
Humacao, Puerto Rico Saturday, April 12, 2025, 11:00 Hrs [IST] ...
Pharmabiz8h
Bausch Health, Canada & pCPA sign LoI for public drug plan coverage of PrCABTREO for treatment of acne vulgaris
Bausch Health, Canada & pCPA sign LoI for public drug plan coverage of PrCABTREO for treatment of acne vulgaris: Laval, Quebec Saturday, April 12, 2025, 10:00 Hrs [IST] Bausch Hea ...
Pharmabiz9h
WHO releases global guidelines for meningitis diagnosis, treatment and care to speed up detection & ensure treatment
WHO releases global guidelines for meningitis diagnosis, treatment and care to speed up detection & ensure treatment: Geneva Saturday, April 12, 2025, 09:00 Hrs [IST] The World He ...
Pharmabiz10h
Biomarkers, precision medicine, early detection to revolutionize CRC care in India: Dr. Sumant Gupta
Biomarkers, precision medicine, early detection to revolutionize CRC care in India: Dr. Sumant Gupta: Shardul Nautiyal, Mumbai Saturday, April 12, 2025, 08:00 Hrs [IST] Molecular ...